Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000019.xml
Download PDF
Fortschr Neurol Psychiatr 2012; 80(7): 382-387
DOI: 10.1055/s-0031-1299473
DOI: 10.1055/s-0031-1299473
Übersicht
Die prämenstruelle dysphorische Störung (PMDS) als eigenständiges Krankheitsbild
Premenstrual Dysphoric Disorder (PMDD) as an Independent DiseaseFurther Information
Publication History
Publication Date:
03 July 2012 (online)
Zusammenfassung
Der Artikel gibt einen Überblick über die prämenstruelle dysphorische Störung (PMDS) und deren klinische Relevanz. Die Abgrenzung zum verallgemeinernden Begriff des prämenstruellen Syndroms soll verdeutlicht werden. Das PMDS ist aufgrund der dargestellten wissenschaftlichen Erkenntnisse zur Epidemiologie, Ätiologie, Symptomatik und Therapie als eigenständiges Störungsbild zu werten, welches nach sachgerechter Diagnose und Therapie eine gute Prognose aufweist. Die vermittelten Informationen sollen helfen, die PMDS bewusster in die psychiatrische Differenzialdiagnostik zu integrieren und praktische Anleitungen für Diagnostik und Therapie aufzeigen.
Abstract
This paper provides an overview of premenstrual dysphoric disorder (PMDD) and its clinical relevance in differentiation to premenstrual syndrome (PMS). Regarding recent research on epidemiology, aetiology, symptoms and therapy, PMDD is a discrete disorder and has a good prognosis in cases of appropriate diagnosis and therapy. The information provided in this review will help to better integrate PMDD into the psychiatric diagnostic process; options for diagnosis and treatment are also presented.
-
Literatur
- 1 Tschudin S, Bertea PC, Zemp E. Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample. Arch Womens Ment Health 2010; 13: 485-494
- 2 Halbreich U, Borenstein J, Pearlstein T et al. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 2003; 28: 1-23
- 3 Dell DL. Premenstrual Syndrome, Premenstrual Dysphoric Disorder, and premenstrual exacerbation of another disorder. Clinical Obstetrics and Gynecology 2004; 47: 568-575
- 4 Krüger S, Schoofs N. Affektive Episoden – Weiblicher Lebenszyklus. Neurotransmitter 2010; 7–8: 2-7
- 5 Schwärzler B, Hautzinger M. Die prämenstruelle dysphorische Störung – Vorschlag zur Diagnostik eines eigenständigen affektiven Störungsbildes. Nervenarzt 2002; 73: 65-70
- 6 American Psychiatric Association. Diagnostic And Statistical Manual Of Mental Disorders-DSM IV. 4th Edition. Washington DC: American Psychiatric Association; 1994
- 7 Wittchen HU, Becker E, Lieb R et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 2002; 32: 119-132
- 8 Tadeka T, Tasaka K. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch Womens Ment Health 2006; 9: 209-212
- 9 ACOG. ACOG practice bulletin:premenstrual syndrome. Int J Gynecol Obstet 2001; 73: 183-191
- 10 Angst J, Sellaro R, Merikangas KR et al. The epidemiology of perimenstrual psychological symptoms. Acta Psychiatr Scand 2001; 104: 110-116
- 11 Spitzer RL, Williams JB, Kroenke K et al. Validity and utility of the PRIME-MD patient health questionnaire of 3000 obstetric-gynecologic patients. Am J Obstet Gynecol 2000; 183: 759-769
- 12 Yonkers KA, Shaughn O’Brien PM, Eriksson E. Premenstrual syndrome. Lancet 2008; 371: 1200-1210
- 13 Rapkin AJ, Pollack DB, Raleigh MJ et al. Menstrual cycle and social behaviour in velvet monkeys. Psychoneuroendocrinology 1995; 20: 289-297
- 14 Rubinow D, Schmidt P. The neuroendocrinoogy of menstrual cycle mood disorders. Ann N Y Acad Sci 1995; 15: 489-493
- 15 Condon JT. The premenstrual syndrome: A twin study. Br J Psychiatry 1993; 162: 481-486
- 16 Erikkson E, Andersch B, Ho HP et al. Diagnosis and treatment of premenstrual dysphoria. J Clin Psychiatry 2002; 63 (Suppl. 07) 16-23
- 17 Pearlstein T, Yonkers K, Fayyad R et al. Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. J Affect Disord 2005; 85: 275-282
- 18 Stute P, Kiesel L. Prämenstruelles Syndrom. Gynäkologische Endokrinologie 2008; 6: 241-248
- 19 Rohde A, Klemme A. Die prämenstruelle dysphorische Störung als schwerste Form des prämenstruellen Syndroms. Geburtsh Frauenheilk 2002; 62 (Suppl. 01) 17-25
- 20 Endicott J, Nee J, Harrison W. Daily Record of Severity of Problems (DRSP): reliability and validity. Arch Womens Ment Health 2006; 9: 41-49
- 21 Steiner M, Macdougall M, Brown E. The premenstrual symptom screening tool (PSST) for clinicians. Arch womens ment health 2003; 6: 203-209
- 22 Bentz D, Steiner M, Meinlschmidt G. SIPS-Screening-Instrument für prämenstruelle Symptome. Nervenarzt
- 23 Landén M, Eriksson E. How does premenstrual dysphoric disorder relate to depression and anxiety disorders?. Depression and Anxiety 2003; 17: 122-129
- 24 Bertone-Johnson ER, Hankinson SE, Johnson SR. Timing of alcohol use and the incidence of premenstrual syndrome and probable premenstrual dysphoric disorder. Journal of Women’s Health 2009; 18 (12) 1945-1953
- 25 Dilling H, Mombour W, Schmidt MH et al. (Hrsg) Weltgesundheitsorganisation (WHO). Internationale Klassifikation Psychischer Störungen. ICD-10 Kapitel V (F): Diagnostische Kriterien für Forschung und Praxis. 4. Aufl. Bern: Hans Huber; 2006
- 26 Dilling H, Mombour W, Schmidt MH (Hrsg) Weltgesundheitsorganisation (WHO). Internationale Klassifikation Psychischer Störungen. ICD-10 Kapitel V (F): Klinisch-diagnostische Leitlinien. 6. Aufl. Bern: Hans Huber; 2008
- 27 Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci 2008; 33: 291-301
- 28 Steiner M, Pearlstein T, Cohen LS et al. Expert Guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. Journal of Women’s Health 2006; 15: 57-69
- 29 European Medicines Agency. Guidelines on the treatment of premenstrual dysphoric disorder (PMDD) 21.7.2011. download 20.9.2011: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/08/WC500110103.pdf
- 30 Wyatt KM, Dimmock PW, Ismail KMK et al. The effectiveness of GnRHa with and without ‘add-back’ therapy in treating premenstrual syndrome: a meta-analysis. BJOG 2004; 111: 585-93
- 31 Domoney C, Panay N, Hawkins A et al. Treatment of premenstrual syndrome with transdermal oestrogen. Int J Obstet Gynaecol 2003; 83 (Suppl. 03) 37
- 32 Kleine-Gunk B. Das prämenstruelle Syndrom. Frauenarzt 2002; 43: 417-422
- 33 Lopez LM, Kaptein AA, Helmerhorst FM. Oral contraceptives containing drospirenone for premenstrual syndrome. Cochrane Database of Systematic Reviews 2009; Issue 2. Art. No.: CD006586
- 34 Lustyk MKB, Gerrish WG, Shaver S. Cognitive-behavioral therapy for premenstrual dysphoric disorder: a systematic review. Arch Womens Ment Health 2009; 12: 85-96
- 35 Stevinson C, Ernst E. Complementary/alternative therapies for premenstrual syndrome: a systematic review of randomized controlled trials. Am J Obstet Gynecol 2001; 185: 227-235
- 36 O´Brien PMS, Bäckström T, Brown C. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Womens Ment Health 2011; 14: 13-21
- 37 Pearlstein T. Premenstrual dysphoric disorder: out of the appendix. Arch Womens Ment Health 2010; 13: 21-23
- 38 Lenzinger E, Diamant K, Vytiska-Binstorfer E et al. Prämenstruelle dysphorische Störung (PMDS) Ein Überblick über Diagnose, Epidemiologie und Therapieansätze. Nervenarzt 1997; 68: 708-718
- 39 Rohde A, Dorsch V. Prämenstruelle dysphorische Störung. In: Möller HJ, Laux G, Kapfhammer HP. Psychiatrie, Psychosomatik, Psychotherapie. 4. Aufl. Berlin: Springer; 2011: 1411-1415